Alessia Fornoni is a Nephrology physician affiliated with University of Miami. OpenAlex indexes 273 publications with 12,186 citations (h-index 59); ClinicalTrials.gov lists 1 registered study matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Nephrology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1611 NW 12th Ave
Box 016960 M851
Miami, FL 331361005
Telephone
305-243-4664Registry record last updated 31 Jan 2013.
Clinical trials
- Rituximab to Prevent Recurrence of Proteinuria
Sponsor: George W. Burke
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
14 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Travere Therapeutics, Inc.Program year202512 payments$19,626openpaymentsdata.cms.gov ↗
- VERTEX PHARMACEUTICALS INCORPORATEDProgram year20255 payments
- Calliditas Therapeutics US Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
61.1%Calcium channel blocker17.7%Amlodipine Besylate72%Nifedipine Er28%Part D<11 patientsStatin10.9%Rosuvastatin Calcium52%Atorvastatin Calcium48%Part D<11 patients+ 4 more classes in this area
Metabolism & gastrointestinal
19.2%SGLT2 inhibitor19.2%Farxiga75%Jardiance26%Part D<11 patientsHormonal (systemic)
15.5%Vitamin D Analog15.5%Paricalcitol100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
12 NIH research awards on record, funded 2009–2026 per NIH RePORTER. The latest:
- APOM deficiency contributes to renal failure in glomerular diseases
University of Miami School of Medicine
FY2026$445,471R01DK136679 - Workshops and Coaching to Foster Career Skills in Newly Funded NIDDK Scholars
University of Miami School of Medicine
FY2026$162,000UE5DK137308
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Kidney lipid dysmetabolism and lipid droplet accumulation in chronic kidney disease
Nature Reviews Nephrology
2023 - Activation of Stimulator of IFN Genes (STING) Causes Proteinuria and Contributes to Glomerular Diseases
Journal of the American Society of Nephrology
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Robert Myerburg, MD
University of Miami
Thomas Hooton, MD
University of Miami
Harry Flynn, MD
University of Miami
Alan Wein, MD
University of Miami
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”